News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 – 3P Solution
Mar 17, 2024, 19:28

The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 – 3P Solution

3P Solution shared a post on LinkedIn:

“Great news coming up!
We are organizing the first edition of the I.N.N.O.V.A.T.E congress – INTERNATIONAL NEOADJUVANT IMMUNOTHERAPY ACROSS CANCERS – that will be held in Naples on July 11th and 12th, 2024.

With this global meeting, we seek to bring together researchers engaged in neoadjuvant immunotherapy clinical and translational research with the goal of highlighting clinical advances, innovative research approaches, as well as possibilities for collaboration and opportunities to harmonize approaches across cancers.

The meeting will take place over two days and will consist of invited speakers, abstract presentations, and panel discussions. Topics will range from disease specific field overviews, pathology, biomarkers, imaging, and patient reported outcomes. Thanks to the Presidency: Paolo Ascierto, Prof Christian Blank, Liz Burton. Stay tuned for the next updates!“

The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 - 3P Solution

Source: 3P Solution/LinkedIn

3P Solution biomarkers cancer I.N.N.O.V.A.T.E congress Imaging immunotherapy Liz Burton Naples neoadjuvant immunotherapy OncoDaily Oncology Paolo A. Ascierto Pathology patient reported outcomes Prof Dr Christian Blank
Special Coverage
Blog
May 10, 2025, 19:04
Elizabeth Ugwoma Awo-Ejeh: Mental stress is something we hardly talk about, yet it's something almost everyone carries
Insight
May 10, 2025, 18:11
Digestive Cancers Europe highlights Sara Ben Hmido’s study on patient perspectives of AI in surgical decision-making
Blog
May 10, 2025, 18:03
April Dorenbosch discussed migrant struggles with cancer care in Europe in Youth Cancer Europe interview
Insight
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
Blog
May 10, 2025, 17:48
Manette Le Grange Highlights ACT for Children Initiative in Pediatric Cancer Care
Blog
May 10, 2025, 17:44
Ashish Shah Explores Viral Mimicry Approach to Glioblastoma at Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research
Science
May 10, 2025, 17:34
Galip Can Uyar: Prediction of 90-day Mortality Among Cancer Patients with Unplanned Hospitalisation
Insight
May 10, 2025, 17:23
Roupen Odabashian reflects on 2025 JAMA study evaluating AI-generated discharge summaries
Drugs
May 10, 2025, 17:11
A*STAR IMCB study led by Valerie Yang identified AZD5153 and Pazopanib drug combination for soft tissue sarcoma treatment
Blog
May 10, 2025, 17:10
Nnamdi Igwe Receives Barry Coller Award for Excellence in Clinical Medicine - Mount Sinai Department of Medicine
Drugs
May 10, 2025, 17:01
FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer